Drug approvals, clinical trials, and news from the pharmaceutical and biotech industry.
NRx Pharmaceuticals (NASDAQ:NRXP) said the U.S. Food and Drug Administration approved its abbreviated new drug application for preservative-free ketamine injection, marking the company’s first approved product and its transition from a development-stage company to a commercial pharmaceutical company
Alphabet's Q3 earnings sparked a sell-off in the stock, and AI jitters returned to markets, dragging on the tech-heavy indexes.
Eli Lilly is set to report earnings Thursday morning, with traders expecting a move that could send the stock to a fresh high.
Eli Lilly stock surged after the drugmaker raised its 2026 sales forecast amid booming sales of its diabetes and obesity treatments.
